アルツハイマー病治療薬のグローバル市場展望2022-2028

• 英文タイトル:Medicines for Alzheimer Disease Treatment Market, Global Outlook and Forecast 2022-2028

Medicines for Alzheimer Disease Treatment Market, Global Outlook and Forecast 2022-2028「アルツハイマー病治療薬のグローバル市場展望2022-2028」(市場規模、市場予測)調査レポートです。• レポートコード:MR2211MG12687
• 出版社/出版日:Market Monitor Global / 2022年11月
• レポート形態:英文、PDF、70ページ
• 納品方法:Eメール(納期:2-3日)
• 産業分類:製薬・ヘルスケア
• 販売価格(消費税別)
  Single User¥438,750 (USD3,250)▷ お問い合わせ
  Enterprise User¥570,375 (USD4,225)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は次の情報を含め、アルツハイマー病治療薬のグローバル市場規模と予測を記載しています。・アルツハイマー病治療薬のグローバル市場:売上、2017年-2022年、2023年-2028年
・アルツハイマー病治療薬のグローバル市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

アルツハイマー病治療薬のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「NMDA受容体拮抗薬」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

アルツハイマー病治療薬のグローバル主要企業は、Daiichi Sankyo Company Limited、 H. Lundbeck A/S、 Novartis AG、 Lupin Pharmaceuticals, Inc、 Actiza Pharmaceutical Private Limited、 Amneal Pharmaceuticals LLC、 AC Immune、 F. Hoffmann-La Roche Ltd、 Janssen Global Services, LLC、 AbbVie Incなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル(MMG)社は、アルツハイマー病治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のアルツハイマー病治療薬市場:タイプ別、2017年-2022年、2023年-2028年
世界のアルツハイマー病治療薬市場:タイプ別市場シェア、2021年
・NMDA受容体拮抗薬、コリンエステラーゼ阻害薬

世界のアルツハイマー病治療薬市場:用途別、2017年-2022年、2023年-2028年
世界のアルツハイマー病治療薬市場:用途別市場シェア、2021年
・病院調剤薬局、小売調剤薬局、オンライン調剤薬局

世界のアルツハイマー病治療薬市場:地域・国別、2017年-2022年、2023年-2028年
世界のアルツハイマー病治療薬市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるアルツハイマー病治療薬のグローバル売上、2017年-2022年
・主要企業におけるアルツハイマー病治療薬のグローバル売上シェア、2021年
・主要企業におけるアルツハイマー病治療薬のグローバル販売量、2017年-2022年
・主要企業におけるアルツハイマー病治療薬のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
Daiichi Sankyo Company Limited、 H. Lundbeck A/S、 Novartis AG、 Lupin Pharmaceuticals, Inc、 Actiza Pharmaceutical Private Limited、 Amneal Pharmaceuticals LLC、 AC Immune、 F. Hoffmann-La Roche Ltd、 Janssen Global Services, LLC、 AbbVie Inc

*************************************************************

・調査・分析レポートの概要
アルツハイマー病治療薬市場の定義
市場セグメント
世界のアルツハイマー病治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のアルツハイマー病治療薬市場規模
世界のアルツハイマー病治療薬市場規模:2021年 VS 2028年
世界のアルツハイマー病治療薬市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのアルツハイマー病治療薬の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業のアルツハイマー病治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:NMDA受容体拮抗薬、コリンエステラーゼ阻害薬
アルツハイマー病治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院調剤薬局、小売調剤薬局、オンライン調剤薬局
アルツハイマー病治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別アルツハイマー病治療薬市場規模 2021年と2028年
地域別アルツハイマー病治療薬売上・予測
北米市場
- アメリカのアルツハイマー病治療薬市場規模2017年-2028年
- カナダのアルツハイマー病治療薬市場規模2017年-2028年
- メキシコのアルツハイマー病治療薬市場規模2017年-2028年
ヨーロッパ市場
- ドイツのアルツハイマー病治療薬市場規模2017年-2028年
- フランスのアルツハイマー病治療薬市場規模2017年-2028年
- イギリスのアルツハイマー病治療薬市場規模2017年-2028年
- イタリアのアルツハイマー病治療薬市場規模2017年-2028年
- ロシアのアルツハイマー病治療薬市場規模2017年-2028年
アジア市場
- 中国のアルツハイマー病治療薬市場規模2017年-2028年
- 日本のアルツハイマー病治療薬市場規模2017年-2028年
- 韓国のアルツハイマー病治療薬市場規模2017年-2028年
- 東南アジアのアルツハイマー病治療薬市場規模2017年-2028年
- インドのアルツハイマー病治療薬市場規模2017年-2028年
南米市場
- ブラジルのアルツハイマー病治療薬市場規模2017年-2028年
- アルゼンチンのアルツハイマー病治療薬市場規模2017年-2028年
中東・アフリカ市場
- トルコのアルツハイマー病治療薬市場規模2017年-2028年
- イスラエルのアルツハイマー病治療薬市場規模2017年-2028年
- サウジアラビアのアルツハイマー病治療薬市場規模2017年-2028年
- UAEのアルツハイマー病治療薬市場規模2017年-2028年

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Daiichi Sankyo Company Limited、 H. Lundbeck A/S、 Novartis AG、 Lupin Pharmaceuticals, Inc、 Actiza Pharmaceutical Private Limited、 Amneal Pharmaceuticals LLC、 AC Immune、 F. Hoffmann-La Roche Ltd、 Janssen Global Services, LLC、 AbbVie Inc
...

This report contains market size and forecasts of Medicines for Alzheimer Disease Treatment in global, including the following market information:
Global Medicines for Alzheimer Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Medicines for Alzheimer Disease Treatment Market Sales, 2017-2022, 2023-2028, (K Tons)
Global top five Medicines for Alzheimer Disease Treatment companies in 2021 (%)
The global Medicines for Alzheimer Disease Treatment market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NMDA Receptor Antagonists Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medicines for Alzheimer Disease Treatment include Daiichi Sankyo Company Limited, H. Lundbeck A/S, Novartis AG, Lupin Pharmaceuticals, Inc, Actiza Pharmaceutical Private Limited, Amneal Pharmaceuticals LLC, AC Immune, F. Hoffmann-La Roche Ltd and Janssen Global Services, LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medicines for Alzheimer Disease Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medicines for Alzheimer Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Medicines for Alzheimer Disease Treatment Market Segment Percentages, by Type, 2021 (%)
NMDA Receptor Antagonists
Cholinesterase Inhibitors
Global Medicines for Alzheimer Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Medicines for Alzheimer Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Medicines for Alzheimer Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Tons)
Global Medicines for Alzheimer Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medicines for Alzheimer Disease Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Medicines for Alzheimer Disease Treatment revenues share in global market, 2021 (%)
Key companies Medicines for Alzheimer Disease Treatment sales in global market, 2017-2022 (Estimated), (K Tons)
Key companies Medicines for Alzheimer Disease Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Daiichi Sankyo Company Limited
H. Lundbeck A/S
Novartis AG
Lupin Pharmaceuticals, Inc
Actiza Pharmaceutical Private Limited
Amneal Pharmaceuticals LLC
AC Immune
F. Hoffmann-La Roche Ltd
Janssen Global Services, LLC
AbbVie Inc

レポート目次

1 Introduction to Research & Analysis Reports
1.1 Medicines for Alzheimer Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medicines for Alzheimer Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medicines for Alzheimer Disease Treatment Overall Market Size
2.1 Global Medicines for Alzheimer Disease Treatment Market Size: 2021 VS 2028
2.2 Global Medicines for Alzheimer Disease Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Medicines for Alzheimer Disease Treatment Sales: 2017-2028
3 Company Landscape
3.1 Top Medicines for Alzheimer Disease Treatment Players in Global Market
3.2 Top Global Medicines for Alzheimer Disease Treatment Companies Ranked by Revenue
3.3 Global Medicines for Alzheimer Disease Treatment Revenue by Companies
3.4 Global Medicines for Alzheimer Disease Treatment Sales by Companies
3.5 Global Medicines for Alzheimer Disease Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Medicines for Alzheimer Disease Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Medicines for Alzheimer Disease Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medicines for Alzheimer Disease Treatment Players in Global Market
3.8.1 List of Global Tier 1 Medicines for Alzheimer Disease Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Medicines for Alzheimer Disease Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medicines for Alzheimer Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 NMDA Receptor Antagonists
4.1.3 Cholinesterase Inhibitors
4.2 By Type – Global Medicines for Alzheimer Disease Treatment Revenue & Forecasts
4.2.1 By Type – Global Medicines for Alzheimer Disease Treatment Revenue, 2017-2022
4.2.2 By Type – Global Medicines for Alzheimer Disease Treatment Revenue, 2023-2028
4.2.3 By Type – Global Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
4.3 By Type – Global Medicines for Alzheimer Disease Treatment Sales & Forecasts
4.3.1 By Type – Global Medicines for Alzheimer Disease Treatment Sales, 2017-2022
4.3.2 By Type – Global Medicines for Alzheimer Disease Treatment Sales, 2023-2028
4.3.3 By Type – Global Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
4.4 By Type – Global Medicines for Alzheimer Disease Treatment Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Medicines for Alzheimer Disease Treatment Market Size, 2021 & 2028
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application – Global Medicines for Alzheimer Disease Treatment Revenue & Forecasts
5.2.1 By Application – Global Medicines for Alzheimer Disease Treatment Revenue, 2017-2022
5.2.2 By Application – Global Medicines for Alzheimer Disease Treatment Revenue, 2023-2028
5.2.3 By Application – Global Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
5.3 By Application – Global Medicines for Alzheimer Disease Treatment Sales & Forecasts
5.3.1 By Application – Global Medicines for Alzheimer Disease Treatment Sales, 2017-2022
5.3.2 By Application – Global Medicines for Alzheimer Disease Treatment Sales, 2023-2028
5.3.3 By Application – Global Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
5.4 By Application – Global Medicines for Alzheimer Disease Treatment Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Medicines for Alzheimer Disease Treatment Market Size, 2021 & 2028
6.2 By Region – Global Medicines for Alzheimer Disease Treatment Revenue & Forecasts
6.2.1 By Region – Global Medicines for Alzheimer Disease Treatment Revenue, 2017-2022
6.2.2 By Region – Global Medicines for Alzheimer Disease Treatment Revenue, 2023-2028
6.2.3 By Region – Global Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
6.3 By Region – Global Medicines for Alzheimer Disease Treatment Sales & Forecasts
6.3.1 By Region – Global Medicines for Alzheimer Disease Treatment Sales, 2017-2022
6.3.2 By Region – Global Medicines for Alzheimer Disease Treatment Sales, 2023-2028
6.3.3 By Region – Global Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Medicines for Alzheimer Disease Treatment Revenue, 2017-2028
6.4.2 By Country – North America Medicines for Alzheimer Disease Treatment Sales, 2017-2028
6.4.3 US Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.4.4 Canada Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.4.5 Mexico Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Medicines for Alzheimer Disease Treatment Revenue, 2017-2028
6.5.2 By Country – Europe Medicines for Alzheimer Disease Treatment Sales, 2017-2028
6.5.3 Germany Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.5.4 France Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.5.5 U.K. Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.5.6 Italy Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.5.7 Russia Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.5.9 Benelux Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Medicines for Alzheimer Disease Treatment Revenue, 2017-2028
6.6.2 By Region – Asia Medicines for Alzheimer Disease Treatment Sales, 2017-2028
6.6.3 China Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.6.4 Japan Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.6.5 South Korea Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.6.7 India Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Medicines for Alzheimer Disease Treatment Revenue, 2017-2028
6.7.2 By Country – South America Medicines for Alzheimer Disease Treatment Sales, 2017-2028
6.7.3 Brazil Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.7.4 Argentina Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medicines for Alzheimer Disease Treatment Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Medicines for Alzheimer Disease Treatment Sales, 2017-2028
6.8.3 Turkey Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.8.4 Israel Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
6.8.6 UAE Medicines for Alzheimer Disease Treatment Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Daiichi Sankyo Company Limited
7.1.1 Daiichi Sankyo Company Limited Corporate Summary
7.1.2 Daiichi Sankyo Company Limited Business Overview
7.1.3 Daiichi Sankyo Company Limited Medicines for Alzheimer Disease Treatment Major Product Offerings
7.1.4 Daiichi Sankyo Company Limited Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Daiichi Sankyo Company Limited Key News
7.2 H. Lundbeck A/S
7.2.1 H. Lundbeck A/S Corporate Summary
7.2.2 H. Lundbeck A/S Business Overview
7.2.3 H. Lundbeck A/S Medicines for Alzheimer Disease Treatment Major Product Offerings
7.2.4 H. Lundbeck A/S Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.2.5 H. Lundbeck A/S Key News
7.3 Novartis AG
7.3.1 Novartis AG Corporate Summary
7.3.2 Novartis AG Business Overview
7.3.3 Novartis AG Medicines for Alzheimer Disease Treatment Major Product Offerings
7.3.4 Novartis AG Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Novartis AG Key News
7.4 Lupin Pharmaceuticals, Inc
7.4.1 Lupin Pharmaceuticals, Inc Corporate Summary
7.4.2 Lupin Pharmaceuticals, Inc Business Overview
7.4.3 Lupin Pharmaceuticals, Inc Medicines for Alzheimer Disease Treatment Major Product Offerings
7.4.4 Lupin Pharmaceuticals, Inc Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Lupin Pharmaceuticals, Inc Key News
7.5 Actiza Pharmaceutical Private Limited
7.5.1 Actiza Pharmaceutical Private Limited Corporate Summary
7.5.2 Actiza Pharmaceutical Private Limited Business Overview
7.5.3 Actiza Pharmaceutical Private Limited Medicines for Alzheimer Disease Treatment Major Product Offerings
7.5.4 Actiza Pharmaceutical Private Limited Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Actiza Pharmaceutical Private Limited Key News
7.6 Amneal Pharmaceuticals LLC
7.6.1 Amneal Pharmaceuticals LLC Corporate Summary
7.6.2 Amneal Pharmaceuticals LLC Business Overview
7.6.3 Amneal Pharmaceuticals LLC Medicines for Alzheimer Disease Treatment Major Product Offerings
7.6.4 Amneal Pharmaceuticals LLC Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Amneal Pharmaceuticals LLC Key News
7.7 AC Immune
7.7.1 AC Immune Corporate Summary
7.7.2 AC Immune Business Overview
7.7.3 AC Immune Medicines for Alzheimer Disease Treatment Major Product Offerings
7.7.4 AC Immune Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.7.5 AC Immune Key News
7.8 F. Hoffmann-La Roche Ltd
7.8.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.8.2 F. Hoffmann-La Roche Ltd Business Overview
7.8.3 F. Hoffmann-La Roche Ltd Medicines for Alzheimer Disease Treatment Major Product Offerings
7.8.4 F. Hoffmann-La Roche Ltd Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.8.5 F. Hoffmann-La Roche Ltd Key News
7.9 Janssen Global Services, LLC
7.9.1 Janssen Global Services, LLC Corporate Summary
7.9.2 Janssen Global Services, LLC Business Overview
7.9.3 Janssen Global Services, LLC Medicines for Alzheimer Disease Treatment Major Product Offerings
7.9.4 Janssen Global Services, LLC Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.9.5 Janssen Global Services, LLC Key News
7.10 AbbVie Inc
7.10.1 AbbVie Inc Corporate Summary
7.10.2 AbbVie Inc Business Overview
7.10.3 AbbVie Inc Medicines for Alzheimer Disease Treatment Major Product Offerings
7.10.4 AbbVie Inc Medicines for Alzheimer Disease Treatment Sales and Revenue in Global (2017-2022)
7.10.5 AbbVie Inc Key News
8 Global Medicines for Alzheimer Disease Treatment Production Capacity, Analysis
8.1 Global Medicines for Alzheimer Disease Treatment Production Capacity, 2017-2028
8.2 Medicines for Alzheimer Disease Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Medicines for Alzheimer Disease Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medicines for Alzheimer Disease Treatment Supply Chain Analysis
10.1 Medicines for Alzheimer Disease Treatment Industry Value Chain
10.2 Medicines for Alzheimer Disease Treatment Upstream Market
10.3 Medicines for Alzheimer Disease Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medicines for Alzheimer Disease Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Medicines for Alzheimer Disease Treatment in Global Market
Table 2. Top Medicines for Alzheimer Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Medicines for Alzheimer Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Medicines for Alzheimer Disease Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Medicines for Alzheimer Disease Treatment Sales by Companies, (K Tons), 2017-2022
Table 6. Global Medicines for Alzheimer Disease Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Medicines for Alzheimer Disease Treatment Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Medicines for Alzheimer Disease Treatment Product Type
Table 9. List of Global Tier 1 Medicines for Alzheimer Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medicines for Alzheimer Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Medicines for Alzheimer Disease Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Medicines for Alzheimer Disease Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Medicines for Alzheimer Disease Treatment Sales (K Tons), 2017-2022
Table 15. By Type - Global Medicines for Alzheimer Disease Treatment Sales (K Tons), 2023-2028
Table 16. By Application – Global Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Medicines for Alzheimer Disease Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Medicines for Alzheimer Disease Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Medicines for Alzheimer Disease Treatment Sales (K Tons), 2017-2022
Table 20. By Application - Global Medicines for Alzheimer Disease Treatment Sales (K Tons), 2023-2028
Table 21. By Region – Global Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Medicines for Alzheimer Disease Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Medicines for Alzheimer Disease Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Medicines for Alzheimer Disease Treatment Sales (K Tons), 2017-2022
Table 25. By Region - Global Medicines for Alzheimer Disease Treatment Sales (K Tons), 2023-2028
Table 26. By Country - North America Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2017-2022
Table 29. By Country - North America Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2023-2028
Table 30. By Country - Europe Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2017-2022
Table 33. By Country - Europe Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2023-2028
Table 34. By Region - Asia Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2017-2022
Table 37. By Region - Asia Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2023-2028
Table 38. By Country - South America Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2017-2022
Table 41. By Country - South America Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2023-2028
Table 42. By Country - Middle East & Africa Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2017-2022
Table 45. By Country - Middle East & Africa Medicines for Alzheimer Disease Treatment Sales, (K Tons), 2023-2028
Table 46. Daiichi Sankyo Company Limited Corporate Summary
Table 47. Daiichi Sankyo Company Limited Medicines for Alzheimer Disease Treatment Product Offerings
Table 48. Daiichi Sankyo Company Limited Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. H. Lundbeck A/S Corporate Summary
Table 50. H. Lundbeck A/S Medicines for Alzheimer Disease Treatment Product Offerings
Table 51. H. Lundbeck A/S Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Novartis AG Corporate Summary
Table 53. Novartis AG Medicines for Alzheimer Disease Treatment Product Offerings
Table 54. Novartis AG Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Lupin Pharmaceuticals, Inc Corporate Summary
Table 56. Lupin Pharmaceuticals, Inc Medicines for Alzheimer Disease Treatment Product Offerings
Table 57. Lupin Pharmaceuticals, Inc Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Actiza Pharmaceutical Private Limited Corporate Summary
Table 59. Actiza Pharmaceutical Private Limited Medicines for Alzheimer Disease Treatment Product Offerings
Table 60. Actiza Pharmaceutical Private Limited Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Amneal Pharmaceuticals LLC Corporate Summary
Table 62. Amneal Pharmaceuticals LLC Medicines for Alzheimer Disease Treatment Product Offerings
Table 63. Amneal Pharmaceuticals LLC Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 64. AC Immune Corporate Summary
Table 65. AC Immune Medicines for Alzheimer Disease Treatment Product Offerings
Table 66. AC Immune Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 67. F. Hoffmann-La Roche Ltd Corporate Summary
Table 68. F. Hoffmann-La Roche Ltd Medicines for Alzheimer Disease Treatment Product Offerings
Table 69. F. Hoffmann-La Roche Ltd Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 70. Janssen Global Services, LLC Corporate Summary
Table 71. Janssen Global Services, LLC Medicines for Alzheimer Disease Treatment Product Offerings
Table 72. Janssen Global Services, LLC Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 73. AbbVie Inc Corporate Summary
Table 74. AbbVie Inc Medicines for Alzheimer Disease Treatment Product Offerings
Table 75. AbbVie Inc Medicines for Alzheimer Disease Treatment Sales (K Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 76. Medicines for Alzheimer Disease Treatment Production Capacity (K Tons) of Key Manufacturers in Global Market, 2020-2022 (K Tons)
Table 77. Global Medicines for Alzheimer Disease Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Medicines for Alzheimer Disease Treatment Production by Region, 2017-2022 (K Tons)
Table 79. Global Medicines for Alzheimer Disease Treatment Production by Region, 2023-2028 (K Tons)
Table 80. Medicines for Alzheimer Disease Treatment Market Opportunities & Trends in Global Market
Table 81. Medicines for Alzheimer Disease Treatment Market Drivers in Global Market
Table 82. Medicines for Alzheimer Disease Treatment Market Restraints in Global Market
Table 83. Medicines for Alzheimer Disease Treatment Raw Materials
Table 84. Medicines for Alzheimer Disease Treatment Raw Materials Suppliers in Global Market
Table 85. Typical Medicines for Alzheimer Disease Treatment Downstream
Table 86. Medicines for Alzheimer Disease Treatment Downstream Clients in Global Market
Table 87. Medicines for Alzheimer Disease Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Medicines for Alzheimer Disease Treatment Segment by Type
Figure 2. Medicines for Alzheimer Disease Treatment Segment by Application
Figure 3. Global Medicines for Alzheimer Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Medicines for Alzheimer Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Medicines for Alzheimer Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Medicines for Alzheimer Disease Treatment Sales in Global Market: 2017-2028 (K Tons)
Figure 8. The Top 3 and 5 Players Market Share by Medicines for Alzheimer Disease Treatment Revenue in 2021
Figure 9. By Type - Global Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Medicines for Alzheimer Disease Treatment Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Medicines for Alzheimer Disease Treatment Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
Figure 19. US Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
Figure 24. Germany Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
Figure 33. China Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Medicines for Alzheimer Disease Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Medicines for Alzheimer Disease Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Medicines for Alzheimer Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Medicines for Alzheimer Disease Treatment Production Capacity (K Tons), 2017-2028
Figure 49. The Percentage of Production Medicines for Alzheimer Disease Treatment by Region, 2021 VS 2028
Figure 50. Medicines for Alzheimer Disease Treatment Industry Value Chain
Figure 51. Marketing Channels



• 英文レポート名:Medicines for Alzheimer Disease Treatment Market, Global Outlook and Forecast 2022-2028
• 日本語訳:アルツハイマー病治療薬のグローバル市場展望2022-2028
• レポートコード:MR2211MG12687お問い合わせ(見積依頼・ご注文・質問)